AWM Investment Company Inc. Cuts Holdings in Aspen Aerogels, Inc. $ASPN

AWM Investment Company Inc. lowered its position in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 41.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,435,477 shares of the construction company’s stock after selling 1,013,744 shares during the quarter. AWM Investment Company Inc. owned 1.74% of Aspen Aerogels worth $8,498,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in ASPN. Nisa Investment Advisors LLC raised its holdings in shares of Aspen Aerogels by 1,094.8% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after purchasing an additional 4,390 shares during the period. SBI Securities Co. Ltd. increased its position in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after purchasing an additional 2,551 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Aspen Aerogels in the first quarter valued at approximately $43,000. Probity Advisors Inc. acquired a new position in Aspen Aerogels during the second quarter valued at approximately $63,000. Finally, FORA Capital LLC purchased a new stake in Aspen Aerogels during the first quarter worth approximately $79,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on ASPN. Zacks Research downgraded shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday. Finally, Barclays lowered their target price on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.67.

Check Out Our Latest Stock Report on Aspen Aerogels

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $3.23 on Friday. The company’s fifty day moving average price is $5.50 and its two-hundred day moving average price is $6.34. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The firm has a market capitalization of $266.55 million, a P/E ratio of -0.87 and a beta of 2.95. Aspen Aerogels, Inc. has a 12 month low of $2.92 and a 12 month high of $14.30.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The business had revenue of $73.02 million for the quarter, compared to analysts’ expectations of $73.42 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.The firm’s revenue was down 37.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.17) earnings per share. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total value of $183,609.35. Following the completion of the sale, the chief executive officer owned 494,011 shares in the company, valued at approximately $1,595,655.53. The trade was a 10.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.